Phil Febbo

Phil Febbo

Former Chief Medical OfficeratIllumina· In proxies 2022–2023

Pay in FY2023-4% from the year before · Illumina stock -38.6% the same year

Phil Febbo was paid $4.5M in FY2023 (Jan), down 4%. Illumina stock fell 38.6% that year.

Pay$100 in the stock at the end of FY21 → $50
Pay is from the Summary Compensation Table of each Illumina proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. IlluminaPublic company · 4 yr
    • Former Chief Medical Officer2022 – Present · 4 yrStock in role -31%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?